A five-year image-based study in people with type 2 diabetes found metformin use was associated with lower odds of developing ...
MedPage Today on MSN
Study Adds Fuel to the Debate Over Cataract Surgery and Wet AMD
Earlier concerns about surgery accelerating AMD progression likely overstated, researcher ...
Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ophthalmologists. Biosimilars may offer cost-effective alternatives, potentially ...
Huron Daily Tribune on MSNOpinion
Savvy Senior: What Medicare won’t pay for in 2026
"To avoid any future health care surprises, can you tell me what original Medicare doesn’t cover in 2026?" ...
Dear Savvy Senior, To avoid any future health care surprises, can you tell me what original Medicare doesn’t cover in 2026? — ...
The origins of the name Okko Health can be traced back to the word okulo, meaning eye in Esperanto – a universal language ...
Another business based at Norwich Research Park that celebrated success in 2025 was Ikarovec, which has developed a solution for intermediate age-related macular degeneration (AMD), which can lead to ...
‘The Pitt’ and ‘Industry’ make their eagerly anticipated returns, ‘28 Years Later: The Bone Temple’ proves a wonderfully ...
Upregulated expression of transcription factors promoting cone identity in late-stage retinal progenitors drives development ...
Researchers say the type 2 diabetes medication metformin may help treat age-related macular degeneration, which could prevent ...
Throughout February, @HopkinsMedicine experts from the Wilmer Eye Institute are available to discuss prevention and ...
Growth is driven by the rapidly aging global population, rising prevalence of chronic diseases such as diabetes, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results